Axsome Therapeutics's (AXSM) AXS-05 Probability of Success Lowered Following Mgmt Chat, PT Shashed to $90 - Truist Securities

January 14, 2022 7:20 AM EST Send to a Friend
Truist Securities analyst Joon Lee lowered the price target on Axsome Therapeutics (NASDAQ: AXSM) to $90.00 (from $160.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login